Boston Scientific Total Liabilities and Share Holders Equity 2010-2024 | BSX

Boston Scientific total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Boston Scientific total liabilities and share holders equity for the quarter ending September 30, 2024 was $37.108B, a 10.44% increase year-over-year.
  • Boston Scientific total liabilities and share holders equity for 2023 was $35.136B, a 8.21% increase from 2022.
  • Boston Scientific total liabilities and share holders equity for 2022 was $32.469B, a 0.74% increase from 2021.
  • Boston Scientific total liabilities and share holders equity for 2021 was $32.229B, a 4.72% increase from 2020.
Boston Scientific Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $35,136
2022 $32,469
2021 $32,229
2020 $30,777
2019 $30,565
2018 $20,999
2017 $19,042
2016 $18,096
2015 $18,133
2014 $17,024
2013 $16,571
2012 $17,154
2011 $21,290
2010 $22,128
2009 $25,177
Boston Scientific Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $37,108
2024-03-31 $36,669
2023-12-31 $35,136
2023-09-30 $34,043
2023-06-30 $33,601
2023-03-31 $32,892
2022-12-31 $32,469
2022-09-30 $31,947
2022-06-30 $32,189
2022-03-31 $32,337
2021-12-31 $32,229
2021-09-30 $31,877
2021-06-30 $31,168
2021-03-31 $30,900
2020-12-31 $30,777
2020-09-30 $30,845
2020-06-30 $30,823
2020-03-31 $30,113
2019-12-31 $30,565
2019-09-30 $26,756
2019-06-30 $24,309
2019-03-31 $23,802
2018-12-31 $20,999
2018-09-30 $20,379
2018-06-30 $19,615
2018-03-31 $19,202
2017-12-31 $19,042
2017-09-30 $18,636
2017-06-30 $18,382
2017-03-31 $17,943
2016-12-31 $18,096
2016-09-30 $17,697
2016-06-30 $17,838
2016-03-31 $17,718
2015-12-31 $18,133
2015-09-30 $18,215
2015-06-30 $17,123
2015-03-31 $16,472
2014-12-31 $17,024
2014-09-30 $16,718
2014-06-30 $16,477
2014-03-31 $16,335
2013-12-31 $16,571
2013-09-30 $16,917
2013-06-30 $16,996
2013-03-31 $16,763
2012-12-31 $17,154
2012-09-30 $16,898
2012-06-30 $17,818
2012-03-31 $21,185
2011-12-31 $21,290
2011-09-30 $21,502
2011-06-30 $21,559
2011-03-31 $22,070
2010-12-31 $22,128
2010-09-30 $22,486
2010-06-30 $23,019
2010-03-31 $22,853
2009-12-31 $25,177
2009-09-30 $26,229
2009-06-30 $26,193
2009-03-31 $26,105
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $130.065B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.220B 25.79
Stryker (SYK) United States $143.322B 32.30
Medtronic (MDT) Ireland $112.498B 16.74
EssilorLuxottica (ESLOY) France $111.686B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.423B 0.00
Haleon (HLN) United Kingdom $43.501B 28.26
GE HealthCare Technologies (GEHC) United States $39.264B 20.36
ResMed (RMD) United States $37.048B 30.44
Terumo (TRUMY) Japan $29.575B 41.77
Koninklijke Philips (PHG) Netherlands $25.012B 19.14
Zimmer Biomet Holdings (ZBH) United States $21.536B 13.71
Insulet (PODD) United States $18.791B 74.86
Baxter (BAX) United States $17.673B 11.51
Smith & Nephew SNATS (SNN) United Kingdom $10.619B 0.00
Bio-Rad Laboratories (BIO) United States $10.338B 35.13
BellRing Brands (BRBR) United States $9.136B 38.63
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $6.084B 14.14
Haemonetics (HAE) United States $4.474B 21.43
TG Therapeutics (TGTX) United States $4.460B 0.00
ICU Medical (ICUI) United States $4.318B 41.21
Prestige Consumer Healthcare (PBH) United States $3.983B 19.75
Perrigo (PRGO) Ireland $3.596B 10.59
Neogen (NEOG) United States $3.517B 40.57
Envista Holdings (NVST) United States $3.509B 26.14
Agios Pharmaceuticals (AGIO) United States $3.368B 0.00
GN Store Nord (GNNDY) Denmark $3.041B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.942B 18.94
LeMaitre Vascular (LMAT) United States $2.342B 56.97
Warby Parker (WRBY) United States $1.964B 0.00
Green Thumb Industries (GTBIF) United States $1.888B 33.04
AtriCure (ATRC) United States $1.826B 0.00
InMode (INMD) Israel $1.630B 9.80
Curaleaf Holdings (CURLF) Canada $1.384B 0.00
AdaptHealth (AHCO) United States $1.357B 9.70
Maravai LifeSciences Holdings (MRVI) United States $1.280B 0.00
BioLife Solutions (BLFS) United States $1.206B 0.00
Owens & Minor (OMI) United States $0.995B 7.77
Phibro Animal Health (PAHC) United States $0.966B 17.04
CeriBell (CBLL) United States $0.962B 0.00
National Vision Holdings (EYE) United States $0.906B 30.29
Capricor Therapeutics (CAPR) United States $0.895B 0.00
Evolus (EOLS) United States $0.866B 0.00
Verano Holdings (VRNOF) United States $0.691B 0.00
Cresco Labs (CRLBF) United States $0.605B 0.00
VAREX IMAGING (VREX) United States $0.582B 17.56
Quanterix (QTRX) United States $0.580B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Valneva SE (VALN) France $0.426B 0.00
Canopy Growth (CGC) Canada $0.398B 0.00
ZimVie (ZIMV) United States $0.393B 33.12
Viemed Healthcare (VMD) United States $0.353B 33.59
Cerus (CERS) United States $0.331B 0.00
OraSure Technologies (OSUR) United States $0.320B 21.45
Sanara MedTech (SMTI) United States $0.308B 0.00
Biote (BTMD) United States $0.301B 13.90
Zynex (ZYXI) United States $0.287B 60.07
Jin Medical (ZJYL) China $0.284B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
TerrAscend (TSNDF) Canada $0.269B 0.00
Aurora Cannabis (ACB) Canada $0.264B 0.00
Omeros (OMER) United States $0.256B 0.00
Utah Medical Products (UTMD) United States $0.236B 15.90
High Tide (HITI) Canada $0.221B 91.67
Brainsway (BWAY) Israel $0.181B 217.20
Organigram Holdings (OGI) Canada $0.172B 0.00
FitLife Brands (FTLF) United States $0.151B 20.39
Rockwell Medical (RMTI) United States $0.137B 0.00
TriSalus Life Sciences (TLSI) United States $0.129B 0.00
Quipt Home Medical (QIPT) United States $0.116B 0.00
Zevia PBC (ZVIA) United States $0.111B 0.00
Veru (VERU) United States $0.107B 0.00
Ayr Wellness (AYRWF) United States $0.104B 0.00
Fonar (FONR) United States $0.095B 9.82
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.10
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.67
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
MariMed (MRMD) United States $0.062B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Exagen (XGN) United States $0.050B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
Nephros (NEPH) United States $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.20
SNDL (SNDL) Canada $0.000B 0.00